Abstract
Phosphate is a common ingredient in many healthy foods but, it is also present in foods containing additives and preservatives. When found in foods, phosphate is absorbed in the intestines and filtered from the blood by the kidneys. Generally, any excess is excreted in the urine. In renal pathologies, however, such as chronic kidney disease, a reduced renal ability to excrete phosphate can result in excess accumulation in the body. This accumulation can be a catalyst for widespread damage to the cellular components, bones, and cardiovascular structures. This in turn can reduce mortality. Because of an incomplete understanding of the mechanism for phosphate homeostasis, and the multiple organ systems that can modulate it, treatment strategies designed to minimize phosphate burden are limited. The Recommended Dietary Allowance (RDA) for phosphorous is around 700 mg/day for adults, but the majority of healthy adult individuals consume far more phosphate (almost double) than the RDA. Studies suggest that low-income populations are particularly at risk for dietary phosphate overload because of the higher amounts of phosphate found in inexpensive, processed foods. Education in nutrition, as well as access to inexpensive healthy food options may reduce risks for excess consumption as well as a wide-range of disorders, ranging from cardiovascular diseases to kidney diseases to tumor formation. Pre-clinical and clinical studies suggest that dietary phosphate overload has toxic and prolonged adverse health effects. Improved regulations for reporting of phosphate concentrations on food labels are necessary so that people can make more informed choices about their diets and phosphate consumption. This is especially the case given the lack of treatments available to mitigate the short and long-term effects of dietary phosphate overload-related toxicity. Phosphate toxicity is quickly becoming a global health concern. Without measures in place to reduce dietary phosphate intake, the conditions associated with phosphate toxicity will likely to cause untold damage to the wellbeing of individuals around the world.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR (2009) Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol 20(2):381–387. https://doi.org/10.1681/asn.2008040349
Bell RR, Draper HH, Tzeng DY, Shin HK, Schmidt GR (1977) Physiological responses of human adults to foods containing phosphate additives. J Nutr 107(1):42–50
Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31(4):607–617
Bobko AA, Eubank TD, Driesschaert B, Dhimitruka I, Evans J, Mohammad R, Tchekneva EE, Dikov MM, Khramtsov VV (2017) Interstitial inorganic phosphate as a tumor microenvironment marker for tumor progression. Sci Rep 7:41233. https://doi.org/10.1038/srep41233
Brown RB, Razzaque MS (2015) Dysregulation of phosphate metabolism and conditions associated with phosphate toxicity. Bonekey Rep 4:705. https://doi.org/10.1038/bonekey.2015.74
Brown RB, Razzaque MS (2016) Phosphate toxicity: a stealth biochemical stress factor? Med Mol Morphol 49(1):1–4. https://doi.org/10.1007/s00795-015-0122-3
Brown RB, Razzaque MS (2018) Phosphate toxicity and tumorigenesis. Biochim Biophys Acta 1869(2):303–309. https://doi.org/10.1016/j.bbcan.2018.04.007
Brown RB, Haq A, Stanford CF, Razzaque MS (2015) Vitamin D, phosphate, and vasculotoxicity. Can J Physiol Pharmacol 93(12):1077–1082. https://doi.org/10.1139/cjpp-2015-0083
Calvo MS (2000) Dietary considerations to prevent loss of bone and renal function. Nutrition 16(7–8):564–566
Cancela AL, Santos RD, Titan SM, Goldenstein PT, Rochitte CE, Lemos PA, dos Reis LM, Graciolli FG, Jorgetti V, Moyses RM (2012) Phosphorus is associated with coronary artery disease in patients with preserved renal function. PLoS One 7(5):e36883. https://doi.org/10.1371/journal.pone.0036883
Chudek J, Nagy A, Kokot F, Podwinski A, Wiecek A, Ritz E, Kovacs G (2007) Phosphatemia is related to chromosomal aberrations of parathyroid glands in patients with hyperparathyroidism. J Nephrol 20(2):164–172
Craver L, Marco MP, Martinez I, Rue M, Borras M, Martin ML, Sarro F, Valdivielso JM, Fernandez E (2007) Mineral metabolism parameters throughout chronic kidney disease stages 1–5–achievement of K/DOQI target ranges. Nephrol Dial Transplant 22(4):1171–1176. https://doi.org/10.1093/ndt/gfl718
DeLuca S, Sitara D, Kang K, Marsell R, Jonsson K, Taguchi T, Erben RG, Razzaque MS, Lanske B (2008) Amelioration of the premature ageing-like features of Fgf-23 knockout mice by genetically restoring the systemic actions of FGF-23. J Pathol 216(3):345–355. https://doi.org/10.1002/path.2409
Dhingra R, Sullivan LM, Fox CS, Wang TJ, D’Agostino RB, Gaziano JM, Vasan RS (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167(9):879–885. https://doi.org/10.1001/archinte.167.9.879
Dominguez JR, Shlipak MG, Whooley MA, Ix JH (2013) Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes. J Am Soc Nephrol 24(4):647–654. https://doi.org/10.1681/asn.2012090894
El-Abbadi MM, Pai AS, Leaf EM, Yang HY, Bartley BA, Quan KK, Ingalls CM, Liao HW, Giachelli CM (2009) Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int 75(12):1297–1307. https://doi.org/10.1038/ki.2009.83
Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, Yu X, Rauch F, Davis SI, Zhang S, Rios H, Drezner MK, Quarles LD, Bonewald LF, White KE (2006) Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38(11):1310–1315. https://doi.org/10.1038/ng1905
Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA (2009) Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 20(2):397–404. https://doi.org/10.1681/asn.2008020141
Gutierrez OM, Anderson C, Isakova T, Scialla J, Negrea L, Anderson AH, Bellovich K, Chen J, Robinson N, Ojo A, Lash J, Feldman HI, Wolf M (2010) Low socioeconomic status associates with higher serum phosphate irrespective of race. J Am Soc Nephrol 21(11):1953–1960. https://doi.org/10.1681/asn.2010020221
Haut LL, Alfrey AC, Guggenheim S, Buddington B, Schrier N (1980) Renal toxicity of phosphate in rats. Kidney Int 17(6):722–731
Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy CP, Bross R, Shinaberger CS, Noori N, Hirschberg R, Benner D, Nissenson AR, Kopple JD (2010) Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 5(3):519–530. https://doi.org/10.2215/cjn.06080809
Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Tandon A, Powe NR, Fink NE, Sadler JH, Weir MR, Abboud HE, Adler SG, Divers J, Iyengar SK, Freedman BI, Kimmel PL, Knowler WC, Kohn OF, Kramp K, Leehey DJ, Nicholas SB, Pahl MV, Schelling JR, Sedor JR, Thornley-Brown D, Winkler CA, Smith MW, Parekh RS (2008) MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40(10):1185–1192. https://doi.org/10.1038/ng.232
Karp HJ, Kemi VE, Lamberg-Allardt CJ, Karkkainen MU (2013) Mono- and polyphosphates have similar effects on calcium and phosphorus metabolism in healthy young women. Eur J Nutr 52(3):991–996. https://doi.org/10.1007/s00394-012-0406-5
Komolprasert V, Turowski P (2015) Food Additives and Packaging (ACS Symposium Series). American Chemical Society ISBN: 9780841230248. https://doi.org/10.1016/j.jsbmb.2018.01.010
Kovesdy CP, Trivedi BK, Anderson JE (2006) Association of kidney function with mortality in patients with chronic kidney disease not yet on dialysis: a historical prospective cohort study. Adv Chronic Kidney Dis 13(2):183–188. https://doi.org/10.1053/j.ackd.2006.01.005
Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K (2008) Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int 73(11):1296–1302. https://doi.org/10.1038/ki.2008.64
Kovesdy CP, Kuchmak O, Lu JL, Kalantar-Zadeh K (2010) Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD. Am J Kidney Dis 56(5):842–851. https://doi.org/10.1053/j.ajkd.2010.06.011
Lin Y, McKinnon KE, Ha SW, Beck GR Jr (2015) Inorganic phosphate induces cancer cell mediated angiogenesis dependent on forkhead box protein C2 (FOXC2) regulated osteopontin expression. Mol Carcinog 54(9):926–934. https://doi.org/10.1002/mc.22153
Mancini FR, Affret A, Dow C, Balkau B, Clavel-Chapelon F, Bonnet F, Boutron-Ruault MC, Fagherazzi G (2017) High dietary phosphorus intake is associated with an increased risk of type 2 diabetes in the large prospective E3N cohort study. Clin Nutr. https://doi.org/10.1016/j.clnu.2017.07.025
Marks J, Debnam ES, Unwin RJ (2013) The role of the gastrointestinal tract in phosphate homeostasis in health and chronic kidney disease. Curr Opin Nephrol Hypertens 22(4):481–487. https://doi.org/10.1097/MNH.0b013e3283621310
Mehrotra R, Kermah D, Fried L, Adler S, Norris K (2008) Racial differences in mortality among those with CKD. J Am Soc Nephrol 19(7):1403–1410. https://doi.org/10.1681/asn.2007070747
Murphy-Gutekunst L (2005) Hidden phosphorus in popular beverages. Nephrol Nurs J 32(4):443–445
Murphy-Gutekunst L (2007) Hidden phosphorus: where do we go from here? J Ren Nutr 17(4):e31–e36
Nakatani T, Ohnishi M, Razzaque MS (2009a) Inactivation of Klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. FASEB J 23(11):3702–3711. https://doi.org/10.1096/fj.08-123992
Nakatani T, Sarraj B, Ohnishi M, Densmore MJ, Taguchi T, Goetz R, Mohammadi M, Lanske B, Razzaque MS (2009b) In vivo genetic evidence for Klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis. FASEB J 23(2):433–441. https://doi.org/10.1096/fj.08-114397
Noori N, Kalantar-Zadeh K, Kovesdy CP, Bross R, Benner D, Kopple JD (2010) Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol 5(4):683–692. https://doi.org/10.2215/CJN.08601209
Ohnishi M, Razzaque MS (2010) Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. Faseb j 24(9):3562–3571. https://doi.org/10.1096/fj.09-152488
Ohnishi M, Nakatani T, Lanske B, Razzaque MS (2009a) In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin d levels. Circ Cardiovasc Genet 2(6):583–590. https://doi.org/10.1161/CIRCGENETICS.108.847814
Ohnishi M, Nakatani T, Lanske B, Razzaque MS (2009b) Reversal of mineral ion homeostasis and soft-tissue calcification of Klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int 75(11):1166–1172. https://doi.org/10.1038/ki.2009.24
Ohnishi M, Kato S, Razzaque MS (2011) Genetic induction of phosphate toxicity significantly reduces the survival of hypercholesterolemic obese mice. Biochem Biophys Res Commun 415(3):434–438. https://doi.org/10.1016/j.bbrc.2011.10.076
Osuka S, Razzaque MS (2012) Can features of phosphate toxicity appear in normophosphatemia? J Bone Miner Metab 30(1):10–18. https://doi.org/10.1007/s00774-011-0343-z
Razzaque MS (2009a) Does FGF23 toxicity influence the outcome of chronic kidney disease? Nephrol Dial Transplant 24(1):4–7. https://doi.org/10.1093/ndt/gfn620
Razzaque MS (2009b) The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol 5(11):611–619. https://doi.org/10.1038/nrendo.2009.196
Razzaque MS (2009c) FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player? Am J Physiol Renal Physiol 296(3):F470–F476. https://doi.org/10.1152/ajprenal.90538.2008
Razzaque MS (2011a) Osteo-renal regulation of systemic phosphate metabolism. IUBMB Life 63(4):240–247. https://doi.org/10.1002/iub.437
Razzaque MS (2011b) Phosphate toxicity: new insights into an old problem. Clin Sci (Lond) 120(3):91–97. https://doi.org/10.1042/cs20100377
Razzaque MS (2013) Phosphate toxicity and vascular mineralization. Contrib Nephrol 180:74–85. https://doi.org/10.1159/000346784
Razzaque MS (2014) Bone-kidney axis in systemic phosphate turnover. Arch Biochem Biophys 561:154–158. https://doi.org/10.1016/j.abb.2014.06.031
Razzaque MS, Lanske B (2006) Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice. Trends Mol Med 12(7):298–305. https://doi.org/10.1016/j.molmed.2006.05.002
Razzaque MS, St-Arnaud R, Taguchi T, Lanske B (2005) FGF-23, vitamin D and calcification: the unholy triad. Nephrol Dial Transplant 20(10):2032–2035. https://doi.org/10.1093/ndt/gfh991
Saito H, Maeda A, Ohtomo S, Hirata M, Kusano K, Kato S, Ogata E, Segawa H, Miyamoto K, Fukushima N (2005) Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 280(4):2543–2549. https://doi.org/10.1074/jbc.M408903200
Sarnak MJ (2003) Cardiovascular complications in chronic kidney disease. Am J Kidney Dis 41(5 Suppl):11–17
Schwarz S, Trivedi BK, Kalantar-Zadeh K, Kovesdy CP (2006) Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol 1(4):825–831. https://doi.org/10.2215/cjn.02101205
Sherman RA, Mehta O (2009) Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis 54(1):18–23. https://doi.org/10.1053/j.ajkd.2009.01.269
Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113(4):561–568. https://doi.org/10.1172/jci19081
Shutto Y, Shimada M, Kitajima M, Yamabe H, Razzaque MS (2011) Lack of awareness among future medical professionals about the risk of consuming hidden phosphate-containing processed food and drinks. PLoS One 6(12):e29105. https://doi.org/10.1371/journal.pone.0029105
Shutto Y, Shimada M, Kitajima M, Yamabe H, Saitoh Y, Saitoh H, Razzaque MS (2013) Inadequate awareness among chronic kidney disease patients regarding food and drinks containing artificially added phosphate. PLoS One 8(11):e78660. https://doi.org/10.1371/journal.pone.0078660
Sitara D, Kim S, Razzaque MS, Bergwitz C, Taguchi T, Schuler C, Erben RG, Lanske B (2008) Genetic evidence of serum phosphate-independent functions of FGF-23 on bone. PLoS Genet 4(8):e1000154. https://doi.org/10.1371/journal.pgen.1000154
Sullivan CM, Leon JB, Sehgal AR (2007) Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients. J Ren Nutr 17(5):350–354. https://doi.org/10.1053/j.jrn.2007.05.008
Takeda E, Yamamoto H, Yamanaka-Okumura H, Taketani Y (2012) Dietary phosphorus in bone health and quality of life. Nutr Rev 70(6):311–321. https://doi.org/10.1111/j.1753-4887.2012.00473.x
Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112(17):2627–2633. https://doi.org/10.1161/circulationaha.105.553198
Uribarri J (2009) Phosphorus additives in food and their effect in dialysis patients. Clin J Am Soc Nephrol 4(8):1290–1292. https://doi.org/10.2215/cjn.03950609
Uribarri J, Calvo MS (2003) Hidden sources of phosphorus in the typical American diet: does it matter in nephrology? Semin Dial 16(3):186–188
van Ballegooijen AJ, Reinders I, Visser M, Brouwer IA (2013) Parathyroid hormone and cardiovascular disease events: A systematic review and meta-analysis of prospective studies. Am Heart J 165(5):655–664. https://doi.org/10.1016/j.ahj.2013.02.014 664.e651–655.
Ward DN, Griffin AC (1955) Phosphorus incorporation into nucleic acids and proteins of liver nuclei of normal and azo dye-fed rats. Cancer Res 15(7):456–461
Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ (2004) Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 15(5):1307–1315
Yoshikawa R, Yamamoto H, Nakahashi O, Kagawa T, Tajiri M, Nakao M, Fukuda S, Arai H, Masuda M, Iwano M, Takeda E, Taketani Y (2018) The age-related changes of dietary phosphate responsiveness in plasma 1,25-dihydroxyvitamin D levels and renal Cyp27b1 and Cyp24a1 gene expression is associated with renal alpha-Klotho gene expression in mice. J Clin Biochem Nutr 62(1):68–74. https://doi.org/10.3164/jcbn.17-20
Zhang YY, Yang M, Bao JF, Gu LJ, Yu HL, Yuan WJ (2018) Phosphate stimulates myotube atrophy through autophagy activation: evidence of hyperphosphatemia contributing to skeletal muscle wasting in chronic kidney disease. BMC Nephrol 19(1):45. https://doi.org/10.1186/s12882-018-0836-2
Acknowledgements
Thanks to Rufsa H. Afroze for carefully reading the manuscript and providing useful suggestions. Dr. Razzaque is a Visiting Professor at the Harvard School of Dental Medicine, Boston (USA), and an Honorary Professor at the University of Rwanda College of Medicine & Health Sciences in Kigali (Rwanda).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Erem, S., Razzaque, M.S. Dietary phosphate toxicity: an emerging global health concern. Histochem Cell Biol 150, 711–719 (2018). https://doi.org/10.1007/s00418-018-1711-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-018-1711-8